ARTICLE | Clinical News
OxiGene preclinical data
April 29, 2002 7:00 AM UTC
In rabbits, systemic CA4P treatment inhibited the growth of abnormal blood vessels in the cornea. In addition, subconjunctival injections of CA4P in a murine retinoblastoma model significantly reduced...